Report ID |
41428 |
Drug Identification Number |
02049481 |
Brand name |
NOVAHISTEX DH |
Common or Proper name |
Novahistex DH 100ml |
Company Name |
SANOFI-AVENTIS CANADA INC |
Market Status |
CANCELLED POST MARKET |
Active Ingredient(s) |
PHENYLEPHRINE HYDROCHLORIDE
HYDROCODONE BITARTRATE |
Strength(s) |
20MG
5MG |
Dosage form(s) |
SYRUP |
Route of administration |
ORAL |
Packaging size |
100ml |
ATC code |
R05DA |
ATC description |
COUGH SUPPRESSANTS EXCL. COMB. WITH EXPECTORANTS |
Reason for shortage |
Demand increase for the drug. |
Anticipated start date |
2018-03-21 |
Actual start date |
|
Estimated end date |
2018-05-16 |
Actual end date |
2018-05-07 |
Shortage status |
Resolved |
Updated date |
2018-05-08 |
Company comments |
|
Health Canada comments |
|
Company contact information |
email: CAINTERNET@sanofi.com
Telephone: 1-800-265-7927 |